Rate My Professor Lawrence Richer

Richer's research focuses on pediatric migraine and headache disorders, as well as pediatric autonomic disorders, including Postural Orthostatic Tachycardia Syndrome (POTS), with investigations into the mechanisms and management of orthostatic intolerance, fatigue, concussion, long COVID, and chronic migraine. He has authored key publications such as the 'Canadian Cardiovascular Society Position Statement on Orthostatic Intolerance' (2020), 'Treatment of Children With Migraine in Emergency Departments' (2010), 'Drugs for the Acute Treatment of Migraine in Children and Adolescents' (Cochrane Review, 2016), 'Emergency Department Management of Acute Migraine in Children and Adolescents' (2007), and recent studies including 'The Healthcare Cost of Migraine: A Retrospective Cohort Study from Alberta, Canada' (2025) and 'Healthcare Cost of Multiple Sclerosis and in Relation to Disability Level in Alberta' (2024). Through his leadership in clinical trials and precision health, Richer influences advancements in pediatric neurology and broader health research platforms at the University of Alberta.